Case Summary (G.R. No. 173587)
Background
Zuellig Pharma Corporation is a domestic corporation specializing in pharmaceutical manufacturing and distribution, including products from Syntex Pharmaceuticals. In 1995, following the acquisition of Syntex by Roche Philippines, Zuellig terminated the employment of its Syntex Division employees, citing redundancy. All terminated employees were duly notified, with separation pay provided as per the March 21, 1995 Collective Bargaining Agreement (CBA) and signed Release and Quitclaims, allowing Zuellig to settle any claims tied to their employment.
Labor Arbiter and NLRC Proceedings
The respondents subsequently filed complaints seeking additional financial benefits, specifically retirement gratuity and unused sick leave compensation, despite having received redundancy pay. The Labor Arbiter ruled against the respondents, clarifying that employees separated due to redundancy do not qualify for retirement benefits. This decision was upheld by the National Labor Relations Commission (NLRC).
Court of Appeals Ruling
The respondents, undeterred, petitioned the Court of Appeals for certiorari relief. The CA overturned the Labory Arbiter's and NLRC's decisions, advocating that the absence of a prohibition in the CBA allowed the respondents to claim both separation pay and retirement benefits. The CA highlighted provisions of the Retirement Gratuity Plan, determining redundancy as not fault-related, mandating Zuellig to compensate the employees accordingly.
Grounds for Petition
Zuellig challenged the CA's ruling, claiming:
- Erroneous interpretation that the CBA and Retirement Gratuity Plan permitted dual benefits.
- Incorrect conclusion on the monetary equivalent of unused sick leave.
- Misjudgment regarding the validity of respondents’ quitclaims.
Arguments and Counterarguments
Zuellig asserted the existence of a specific CBA provision that prohibits recovery of both redundancy pay and retirement gratuity. They pointed to legal precedents, including the case of Aquino v. NLRC, which they contended was inapplicable due to the presence of an express prohibition in the CBA. Respondents maintained that the terms of the CBA did not distinctly restrict dual recovery and argued the choice made was based on the non-employment-related cause of their separation.
Supreme Court Ruling
The Supreme Court found merit in Zuellig's position, emphasizing that the CBA stipulated terms precluding employees from claiming both benefits. The CBA was also underscored as a law between the contracting parties, mandating their compliance with its agreed-upon provisions. The interpretation of terms was pivotal; thus, the merger of benefits under Article XIV of the CBA concluded that acceptance of redundancy pay barred claims for retirement gratuity. The ruling reinstated the NLRC's decision, affirming that the respondents were only entitled to redundancy pay.
Validation of the Release and Quitclaim
The Court upheld the validity
...continue readingCase Syllabus (G.R. No. 173587)
Case Citation
- 714 Phil. 33
- G.R. No. 173587
- Date of Decision: July 15, 2013
- Second Division
Parties Involved
- Petitioner: Zuellig Pharma Corporation
- Respondents: Alice M. Sibal, Ma. Teresa J. Bariso, Prescillano L. Gonzales, Laura B. Bernardo, Mamerta R. Zita, Josephine Judy C. Garcia, and 30 others.
Procedural Background
- The petition for review on certiorari challenges the December 4, 2003 Decision of the Court of Appeals (CA) in CA-G.R. SP No. 50448, which annulled the January 21, 1998 Decision of the National Labor Relations Commission (NLRC) in NLRC NCR CA NO. 011914-96.
- The NLRC had affirmed the August 6, 1996 Decision of the Labor Arbiter, which denied the respondents' claims for retirement gratuity and unused sick leave payment in addition to redundancy pay.
Factual Antecedents
- Petitioner’s Profile: Zuellig Pharma Corporation is a domestic corporation engaged in the manufacture and distribution of pharmaceutical products and also distributes products from other manufacturers like Syntex Pharmaceuticals.
- Respondents’ Employment: The respondents were employees of Zuellig at its Syntex Division. In 1995, Roche Philippines, Inc. acquired Syntex, leading to the closure of Zuellig's Syntex Division and the termination of respondents’ employment due to redundancy.
- Termination Process: The respondents were properly notified of their termination and received their respective separation pays as per the Collective Bargaining Agreement (CBA) dated March 21, 1995, which they acknowledged by signing a Release and Quitclaim.
Proceedings Before the Labor Arbiter and NLRC
- Respondents filed separate complaints for retirement gratuity and the monetary equivalent of unused sick leave, asserting entitlement despite having received separation pay.
- The Labor Arbiter denied these claims, stating that only employees separated due to sickness, death, ret